3002.12.00.90/IVIG for Guillain-Barré Syndrome/Canada

IVIG for Guillain-Barré Syndrome from Canada

Intravenous immunoglobulin pooled from thousands of donors, used therapeutically for Guillain-Barré and other neuropathies. Falls under HTS 3002.12.0090 as modified blood fraction immunological product. Bioprocessing includes pathogen reduction for safety.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Pool donor serology and IgG subclass profiles in import dossier